Direct costs of managing Parkinson's disease in india: Concerns in a developing country
Citations Over TimeTop 24% of 2006 papers
Abstract
Medicines and surgical interventions improve the quality of life of Parkinson's disease (PD) patients. These are still expensive options and are unaffordable to those living in developing countries. Managing PD in Indians who have a low annual gross national income (GNI; 450-540 US dollars) and for whom only a few (3%) have health insurance is a challenge. We interviewed 175 consecutive PD patients regarding health insurance and money spent for treatment. The annual income of nearly half the patients was less than rupees 50,000 (1,148.63 US dollars). Patients in this study spend nearly 16% to 41.7% of the average Indian GNI to buy medicines. Costs of treating PD in India are lower than those in developed nations but are still out of reach for most Indian patients.
Related Papers
- → Why Gross National Disposable Income Should Replace Gross National Income(2016)8 cited
- Why Gross National Disposable Income should substitute Gross National Income(2014)
- → National income(2011)
- → National Income(2010)
- 薬剤性Parkinson症候群 (7月第1土曜特集 Parkinson病) -- (Parkinson症候群)(1998)